Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorÇırak, Veli Yılgör
dc.contributor.authorAkşit, Dilek
dc.contributor.authorCihan, Hüseyin
dc.contributor.authorGökbulut, Cengiz
dc.date.accessioned2019-08-29T10:32:40Z
dc.date.available2019-08-29T10:32:40Z
dc.date.issued2018en_US
dc.identifier.issn0048-0169
dc.identifier.issn1176-0710
dc.identifier.urihttps://doi.org/10.1080/00480169.2018.1426504
dc.identifier.urihttps://hdl.handle.net/20.500.12462/6060
dc.descriptionAkşit, Dilek (Balikesir Author)en_US
dc.description.abstractAIMS: To determine the plasma disposition and concentrations of ivermectin (IVM) in eggs produced by laying hens following S/C, oral and I/V administration.METHODS: Twenty-four laying hens, aged 37 weeks and weighing 1.73 (SD 0.12) kg were allocated to three groups of eight birds. The injectable formulation of IVM was administered either orally, S/C, or I/V, at a dose of 0.2mg/kg liveweight, following dilution (1:5, v/v) with propylene glycol. Heparinised blood samples were collected at various times between 0.25 hours and 20 days after drug administration. Eggs produced by hens were also collected daily throughout the study period. Samples of plasma and homogenised egg were analysed using HPLC.RESULTS: Maximum concentrations of IVM in plasma and mean residence time of IVM were lower after oral (10.2 (SD 7.2) ng/mL and 0.38 (SD 0.14) days, respectively) than after S/C (82.9 (SD 12.4) ng/mL and 1.05 (SD 0.24) days, respectively) administration (p<0.01). The time to maximum concentration and elimination half-life were shorter following oral (0.14 (SD 0.04) and 0.23 (SD 0.11) days, respectively) than S/C (0.25 (SD 0.00) and 1.45 (SD 0.45) days, respectively) administration (p<0.01). IVM was first detected in eggs 2 days after treatment in all groups and was detected until 8 days after oral and I/V administration, and until 15 days after S/C administration. Peak concentrations of IVM were 15.7, 23.3 and 1.9 mu g/kg, observed 2, 5 and 4 days after I/V, S/C and oral administration, respectively.CONCLUSIONS AND CLINICAL RELEVANCE: The low plasma bioavailability of IVM observed after oral administration in laying hens could result in lower efficacy or subtherapeutic plasma concentrations, which may promote the development of parasitic drug resistance. Due to high IVM residues in eggs compared to the maximum residue limits for other food-producing animal species, a withdrawal period should be necessary for eggs after IVM treatment in laying hens.en_US
dc.language.isoengen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.isversionof10.1080/00480169.2018.1426504en_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectLaying Hensen_US
dc.subjectPoultryen_US
dc.subjectEndectocidesen_US
dc.subjectAnthelminticen_US
dc.subjectIvermectinen_US
dc.subjectPharmacokineticsen_US
dc.subjectEggen_US
dc.subjectResidueen_US
dc.titlePlasma dispositions and concentrations of ivermectin in eggs following treatment of laying hensen_US
dc.typearticleen_US
dc.relation.journalNew Zealand Veterinary Journalen_US
dc.contributor.departmentVeteriner Fakültesien_US
dc.contributor.authorID0000-0002-4912-7307en_US
dc.contributor.authorID0000-0001-6 595-7821en_US
dc.identifier.volume66en_US
dc.identifier.issue3en_US
dc.identifier.startpage121en_US
dc.identifier.endpage125en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster